1. Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes. Issue 10 (11th August 2020) Authors: Pribyl, Miroslav; Hubackova, Sona; Moudra, Alena; Vancurova, Marketa; Polackova, Helena; Stopka, Tomas; Jonasova, Anna; Bokorova, Radka; Fuchs, Ota; Stritesky, Jan; Salovska, Barbora; Bartek, Jiri; Hodny, Zdenek Journal: Molecular oncology Issue: Volume 14:Issue 10(2020) Page Start: 2403 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cells of the Immune System. (2020) Editors: Fuchs, Ota; Athari, Seyyed Shamsadin Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High level of full‐length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide. (31st October 2014) Authors: Jonasova, Anna; Bokorova, Radka; Polak, Jaroslav; Vostry, Martin; Kostecka, Arnost; Hajkova, Hana; Neuwirtova, Radana; Siskova, Magda; Sponerova, Dana; Cermak, Jaroslav; Mikulenkova, Dana; Cervinek, Libor; Brezinova, Jana; Michalova, Kyra; Fuchs, Ota Journal: European journal of haematology Issue: Volume 95:Number 1(2015:Jul.) Page Start: 27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Important Genes in the Pathogenesis of 5q- Syndrome and Their Connection with Ribosomal Stress and the Innate Immune System Pathway. (13th February 2012) Authors: Fuchs, Ota Other Names: Cilloni Daniela Academic Editor. Journal: Leukemia research and treatment Issue: Volume 2012(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lenalidomide treatment in lower risk myelodysplastic syndromes—The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients). (June 2018) Authors: Jonasova, Anna; Neuwirtova, Radana; Polackova, Helena; Siskova, Magda; Stopka, Tomas; Cmunt, Eduard; Belickova, Monika; Moudra, Alena; Minarik, Lubomir; Fuchs, Ota; Michalova, Kyra; Zemanova, Zuzana Journal: Leukemia research Issue: Volume 69(2018) Page Start: 12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Multiple myeloma. (2021) Editors: Fuchs, Ota Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting cereblon in hematologic malignancies. (January 2023) Authors: Fuchs, Ota Journal: Blood reviews Issue: Volume 57(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Targeting the phosphatidylinositol 3-kinase signaling pathway in acute myeloid leukemia. Issue 4 (2020) Authors: Fuchs, Ota Journal: Integrative cancer science and therapeutics Issue: Volume 7:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗